CoChat

Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans

Open access
van Loon, Luc J. C., Thomason-Hughes, Michaela, Constantin-Teodosiu, Dumitru, Koopman, René, Greenhaff, Paul L., Hardie, D. Grahame, Keizer, Hans A., Saris, Wim H. M., Wagenmakers, Anton J. M. · 2005 · American Journal of Physiology-Endocrinology and Metabolism
Cited by 87

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

This study investigates the consequences of inhibition of adipose tissue lipolysis on skeletal muscle substrate use. Ten subjects were studied at rest and during exercise and subsequent recovery under normal, fasting conditions (control trial, CON) and following administration of a nicotinic acid analog (low plasma free fatty acid trial, LFA). Continuous [U-13 C]palmitate and [6,6-2 H 2]glucose infusions were applied to quantify plasma free fatty acid (FFA) and glucose oxidation rates and to estimate intramuscular triacylglycerol (IMTG) and glycogen use. Muscle biopsies were collected to measure 1) fiber type-specific IMTG content; 2) allosteric regulators of hormone-sensitive lipase (HSL), glycogen phosphorylase, and pyruvate dehydrogenase; and 3) the phosphorylation status of HSL at Ser 563 and Ser 565. Administration of a nicotinic acid analog (acipimox) substantially reduced plasma FFA rate of appearance and subsequent plasma FFA concentrations ( P < 0.0001). At rest, this substantially reduced plasma FFA oxidation rates, which was compensated by an increase in the estimated IMTG use ( P < 0.05). During exercise, the progressive increase in FFA rate of appearance, uptake, and oxidation was prevented in the LFA trial and matched by greater IMTG and glycogen use. Differential phosphorylation of HSL or relief of its allosteric inhibition by long-chain fatty acyl-CoA could not explain the increase in muscle TG use, but there was evidence to support the contention that regulation may reside at the level of the glucose-fatty acid cycle. This study confirms the hypothesis that plasma FFA availability regulates both intramuscular lipid and glycogen use in vivo in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00092.2005

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 87

Metadata

Authors
van Loon, L. J. C., Thomason-Hughes, M., Constantin-Teodosiu, D., Koopman, R., Greenhaff, P. L., Hardie, D. G., Keizer, H. A., Saris, W. H. M., & Wagenmakers, A. J. M.
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2005-09
Volume
289
Issue
3
Pages
E482-E493
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2122078756
Cited by
87
References
24
FWCI
4.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans. https://app.cochat.ai/papers/10.1152/ajpendo.00092.2005
The paper
van Loon, L. J. C., Thomason-Hughes, M., Constantin-Teodosiu, D., Koopman, R., Greenhaff, P. L., Hardie, D. G., Keizer, H. A., Saris, W. H. M., & Wagenmakers, A. J. M. (2005). Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00092.2005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.